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Abstract
A 25-year-old woman presented with ophthalmic and neurological manifestations. Her ocular manifestations included
bilateral uveitis, multifocal retinal phlebitis, vitreitis and multiple retinal haemorrhages. Her neurological manifestations
included migrainous headaches with visual aura, transient sensory symptoms and posterior circulation Transient Ischemic
Attack (TIA). Magnetic resonance imaging of the brain demonstrated lesions that involved the deep white matter lesions
initially and progressed to also involve the juxta cortical white and deep grey matter and brain stem, but without further
neurological manifestations. She was sequentially treated with intravenous and oral glucocorticoid, cyclophosphamide and
mycophenolate mofetil, but she continued to suffer with persistent episodes of retinal haemorrhages. Cerebral Autosomal
Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), Susac syndrome and Behcet’s
disease were considered in the differential diagnosis. Genetic workup and clinical picture were not suggestive of the former
two. Further history of oro-genital ulceration in younger age emerged, which pointed strongly towards a diagnosis of
Behcet’s disease with neurological involvement. She was treated with infliximab and methotrexate with complete
resolution of her symptoms and withdrawal of corticosteroids for the first time in over two decades.
CASE REPORT
A 25-year-old woman presented in 1994 to the ophthalmology
department with sustained episodes of flashes affecting the
vision in both eyes. She was morbidly obese weighing 140 kg
and a smoker. On examination, her optic discs and fundi were
normal, but she was noted to have a transient drop in her visual
acuity that normalized over a few days. For the on-going trouble-
some migrainous phenomenon, she was referred to neurology
where she reported episodes of blurred vision, paraesthesia
in the left lower jaw, left arm and leg. She was experiencing
monthly right-sided headaches, associated with photophobia,
which resolved within 24 hours. Examination was normal with
no evidence of focal neurological deficit. Multiple sclerosis was
considered as a diagnosis but later deemed unlikely. She was
thought to have complicated migraine, and she was discharged.
In 1998, she was re-referred to the neurology department
with intermittent tingling on both sides of her body. This was
accompanied by a sensation of imbalance. She had some
short lasting visual obscuration. Neurological examination was
normal. A magnetic resonance imaging (MRI) of the brain was
organized but could not be performed due to morbid obesity.
In 2002, she presented to the emergency eye department with
bilateral granulomatous uveitis. Retinal fundoscopy revealed
multifocal retinal periphlebitis. The optic discs appeared
healthy, and there was no retinal cystoid macular oedema.
Blood tests showed a normal ANA, antiphospholipid screen,
full blood count, an ESR of 28 mm/hour and the presence
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Figure 1: MRI of the brain in 2002 demonstrating lesions that involved the deep
white matter.
Figure 2: MRI of the brain in 2005 demonstrating progression of the number and
distribution of white matter lesions with multifocal deep grey matter and brain
stem involvement (on lower sections not shown).
of an atypical ANCA. The ANCA prompted a referral to the
rheumatology department. An MRI of the brain showed lesions
that involved the deep white matter (Fig. 1). Over the next
few years, she was monitored in a combined rheumatology–
neurology clinic. Neurological examination remained normal.
A Lumbar Puncture (LP) was not performed due to the body
habitus. Visual evoked potentials were normal. Between 2002
and 2004, she had episodes of vitritis, hypopyon and macular
oedema needing large doses of oral prednisolone. There was
debate about this being a demyelinating process versus a
vasculitis process, and it was decided that she should be treated
with six cycles of intravenous cyclophosphamide followed by
mycophenolate mofetil. However, in spite of the treatment, in
2005 she had a further episode of retinal haemorrhage and a
posterior circulation transient ischaemic attack. A repeat MRI of
the brain revealed progression of the number and distribution of
white matter lesions with multifocal deep grey matter and brain
stem involvement (Fig. 2). Considering this to represent small
vessel disease, possibly due to vasculitis, she was commenced
on aspirin, b-blocker and statin. From 2004–2010, she continued
to have attacks of uveitis and retinal bleeds, which were treated
with a high dose of prednisolone. At this stage, an MRI was
repeated to monitor the central nervous system changes. The
MRI demonstrated progressive disease, which is, though non-
specific, more suggestive of multifocal small vessel disease.
The unusual distribution of the lesions and clinical progression
sparked the search for alternative diagnoses. A review of the
entire history and a multi-disciplinary discussion between
the ophthalmology, rheumatology and neurology departments
considered potential differential diagnoses—CADASIL, Susac
syndrome and neurological Behcet’s disease. A negative genetic
screen ruled out CADASIL. The lack of auditory involvement
made Susac syndrome unlikely. Further history of intermittent
oral and vaginal ulcers in her teens was obtained. This history
had been lost because the patient had not considered this to
be important and this had not been a problem for a number of
years because of on-going oral prednisolone (doses of >10 mg
daily). A clinical diagnosis of Behcet’s disease was made. She
fulfilled the classification criteria as set by the International
Study Group for Behcet’s disease [1]. She was commenced on
infliximab and azathioprine in 2013, which was later switched
to methotrexate due to azathioprine intolerance. Since then she
had no further episodes of uveitis, and her subsequent MRIs
of the brain revealed stable appearances. At last follow-up she
remained stable and is back in full-time employment.
DISCUSSION
Behçet’s disease is a systemic vasculitis of unknown aetiology
involving vessels of all sizes, characterized by orogenital
ulceration, ocular and neurological involvement. Its clinical
manifestations may not occur simultaneously; therefore, a
high index of suspicion is required, and a detailed past history
is crucial to its diagnosis [2]. A diagnosis of cerebral and
retinal vasculitis had been made and sustained in medical
notes in our patient. The finding of temporal lobe atrophy in
such a young woman caused us to look for more sustainable
diagnoses—leading to a definite diagnosis of Behcet’s disease.
She presented initially with vague migrainous headaches
with visual aura, transient sensory symptoms and episodes
of blurred vision. Initial ophthalmological and neurological
examinations were normal. Years later she re-presented with
bilateral uveitis, which persisted for years, and also developed a
posterior circulation stroke. She was treated for retinal vasculitis
with systemic immunosuppression (cyclophosphamide and
mycophenolate mofetil) with recurrence of uveitis episodes
[3]. Interestingly her neurological examination and cognition
remained normal throughout the years. Her MRI of the brain
demonstrated progressive white matter, deep grey matter
and brain stem disease consistent with multifocal small
vessel disease. Her non-response to treatment triggered a
re-consideration of her case after many years of having been
classified as cerebral and retinal vasculitis. Further history
elicited a past episode of oral and genital ulcers in her teen age
years, which she did not complain of because they had always
been steroid responsive, and she did not consider them to be
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relevant. On the basis of the MRI lesions, re-current episodes of
uveitis and orogenital ulcers, she was diagnosed with Behçet’s
disease and commenced on Infliximab and azathioprine as
per the EULAR recommendations [4–6]. Correct identification
of the nature of the vasculitis illness and treating it with the
correct medication resulted in excellent long-term outcomes
resulting in no further retinal bleeds and a return to full-time
employment.
KEY LEARNING POINTS
It is important to re-evaluate patients with long-term diagnoses
when the clinical profile does not fit. It is easy to be biased
with previously made diagnoses. But logical re-interpretation of
existing data can provide plausible alternatives.
Classification of vasculitis is not just for academic purposes.
Correct classification leads to correct medical treatment, which
in-turn leads to better patient-related outcomes.
Behcet’s disease is a clinical diagnosis that can present with
sequential manifestations. Vasculitis should be thought of as a
diagnosis in all patients with multi-organ involvement.
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